Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Virax Biolabs Group Stock Price, Quotes and Forecasts | NASDAQ:VRAX | Benzinga

Q: What sector and industry does Virax Biolabs Group (VRAX) operate in?

Virax Biolabs Group is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Explore Virax Biolabs Group stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VRAX.

Open	$1.03
Close	$1.03
Volume / Avg.	35.78K / 261.02K
Day Range	$1.00 - $1.05
52 Wk Range	0.60 - 9.00
Market Cap	$4.43M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	3.43%
Days to Cover	1.54

Recent News

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

Virax Biolabs' T-cell testing platform targets post-viral syndromes like Long COVID. HC Wainwright sees a major market opportunity, setting a $3 price target.

Vandana Singh

EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency

Virax Biolabs supports HHS's focus on vaccine efficacy transparency, offering technology to assess immune responses and collaborate with developers to improve vaccine research.

Vandana Singh

Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.03
Close	$1.03
Volume / Avg.	35.78K / 261.02K
Day Range	$1.00 - $1.05
52 Wk Range	0.60 - 9.00
Market Cap	$4.43M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	3.43%
Days to Cover	1.54

About Virax Biolabs Group Ltd

Sector

Health Care

Industry

Health Care Providers & Services

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis a...

Got Questions? Ask

How has VRAX's EPS changed?

How is VRAX's EV/EBITDA ratio?

How is VRAX's ROE trending?

What are analysts' targets for VRAX?

What is VRAX's current ratio?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Virax Biolabs Group (VRAX) stock?

You can purchase shares of Virax Biolabs Group (NASDAQ:VRAX) through any online brokerage.

View our list of the best stock brokerages

Who are Virax Biolabs Group (VRAX) competitors?

Other companies in Virax Biolabs Group’s space includes: Akso Health (NASDAQ:AHG), McKesson (NYSE:MCK), Henry Schein (NASDAQ:HSIC), Patterson Cos (NASDAQ:PDCO) and Cencora (NYSE:COR).

What is the forecast, or price target, for Virax Biolabs Group (VRAX) stock?

Virax Biolabs Group has a consensus price target of $3.00.

What is the current price for Virax Biolabs Group (VRAX)?

The stock price for Virax Biolabs Group (NASDAQ: VRAX) is $1.02 last updated April 16, 2025 at 8:18 AM EDT.

Does Virax Biolabs Group (VRAX) pay a dividend?

There are no upcoming dividends for Virax Biolabs Group.

When is Virax Biolabs Group (NASDAQ:VRAX) reporting earnings?

Virax Biolabs Group does not have any upcoming earnings scheduled.

Is Virax Biolabs Group (VRAX) going to split?

There is no upcoming split for Virax Biolabs Group.

What sector and industry does Virax Biolabs Group (VRAX) operate in?

Virax Biolabs Group is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Comments

Virax Biolabs Group Stock Price, Quotes and Forecasts

Virax Biolabs Group (VRAX) Forecast